Tuesday, June 11, 2019
8 a.m. – 2:45 p.m.
The Ohio State University
115 Biomedical Research Tower
460 W. 12th Avenue, Columbus, OH
This conference is presented by the Ohio State University Center for Clinical and Translational Science, in collaboration with the Office of Responsible Research Practices and Nationwide Children’s Hospital.
Experts from The Ohio State University Wexner Medical Center, College of Veterinary Medicine and Nationwide Children’s Hospital will cover topics including the use of animal models for phase one drug development, biologics and the FDA submission process, risk management and audit preparation.
David Burrow, Director, Office of Scientific Investigations, Center for Drug Evaluation and Research, FDA, will be the keynote speaker.
A complimentary lunch will be provided. Registration is limited to 150 participants.